In a May 4, 2018 press release, Utah Southwestern Medical Center research has show that targeting metabolism of growing cells, holds promise for treatment of ‘proliferative’ skin diseases like psoriasis, granuloma annulare and eczema. A research team using mice, demonstrated that inhibiting glucose transport may be a safe and effective treatment for actively dividing cells that are dependent on glucose for growth. Their findings were recently published in ‘Nature Medicine’. People suffering from hyperproliferative skin disorders are at increased risk for other inflammatory diseases such as arthritis, heart disease/hypertension, diabetes, Crohn’s disease, lupus, irritable bowel syndrome, depression, and obesity. Providers are advised to include skin condition inquiries on intake forms and refer or treat in scope, when seeing patients with hyperproliferative skin conditions.